CAM HSBIOTECH

3069
14.5501.82% ( -0.270 )
Delay Closed: Nov 16, 16:08:11

Wiki

About

The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Hang Seng Hong Kong-Listed Biotech Index.

Name
CAM HSBIOTECH
Index tracked
Hang Seng HK-Listed Biotech TR HKD
Type
Equity
Expense ratio
--
Management fee
0.5%
Dividend policy
Annually
NAV
HKD 14.8199 (11/12/2026)
Issued units
258.20M (11/13/2026)
Listing date
Mar 17, 2021
Sponsor
China Asset Management (HK) Limited
Custodian
--

ETF Documents

Last updatedType
10/30/2026Prospectus
10/20/2026Factsheet
05/21/2026Annual Report